Desperate patients get access to unapproved drug for stomach paralysis
NCT ID NCT04996134
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This program allows people aged 12 and older with severe stomach or gut problems, like gastroparesis, to try domperidone when standard treatments have failed. The goal is to ease symptoms such as nausea, vomiting, and severe indigestion. The drug is not FDA-approved but is available through expanded access for those who qualify.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC CONSTIPATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aurora BayCare Medical Center
Green Bay, Wisconsin, 54311, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a skin patch ease stomach pain in scleroderma?
- Could a tailored diet quiet the burn of acid reflux?
- Can surgery offer lasting relief for chronic heartburn? a large registry investigates
- Can big data unlock better GERD treatment for chinese patients?
- Could a botox shot in the gut ease Kids' chronic vomiting?
- Can writing poetry ease anxiety for those with stomach disorders?